FDA updates labeling for HYDROCODONE BITARTRATE AND IBUPROFEN
Labeling changes approved for AMNEAL PHARMS NY. Active ingredient: HYDROCODONE BITARTRATE; IBUPROFEN. Decision date: 12/22/2025
Labeling changes approved for AMNEAL PHARMS NY. Active ingredient: HYDROCODONE BITARTRATE; IBUPROFEN. Decision date: 12/22/2025
There are no comments here yet...